4//SEC Filing
Lyons C Neil 4
Accession 0001171843-12-002423
CIK 0001318641other
Filed
Jun 27, 8:00 PM ET
Accepted
Jun 28, 9:35 PM ET
Size
4.9 KB
Accession
0001171843-12-002423
Insider Transaction Report
Form 4
Lyons C Neil
Chief Financial Officer
Transactions
- Award
Common stock, par value $0.005 per share
2012-06-26+20,273→ 20,273 total
Footnotes (1)
- [F1]These shares of restricted stock were granted to the reporting person under the Equity Incentive Plan, as amended, of Cleveland BioLabs, Inc. (the "Company"). The reporting person has elected to receive these shares of restricted stock in lieu of a portion of his cash salary. These shares of restricted stock will become fully vested on December 16, 2012, unless the reporting person ceases to be an employee or an affiliate of the Company.
Issuer
CLEVELAND BIOLABS INC
CIK 0001318641
Entity typeother
Related Parties
1- filerCIK 0001324648
Filing Metadata
- Form type
- 4
- Filed
- Jun 27, 8:00 PM ET
- Accepted
- Jun 28, 9:35 PM ET
- Size
- 4.9 KB